Antiviral activity of oxetanocins against varicella-zoster virus.
AUTOR(ES)
Sakuma, T
RESUMO
Several new nucleosides with an oxetanosyl-N-glycoside group, named oxetanocins, were evaluated for their antiviral activities against varicella-zoster virus (VZV) in human embryo lung cells. 9-(2-deoxy-2-hydroxy-methyl-beta-D-erythro-oxetanosyl)guanine (OXT-G) and 9-(2-deoxy-2-hydroxymethyl-beta-D-erythro-oxetanosyl)-2- aminoadenine were effective against not only thymidine kinase-positive (TK+) VZV (YS strain) but also thymidine kinase-negative (TK-) VZV (YSR strain), whereas carbocyclic OXT-G was effective against TK+ VZV but not against TK- VZV. [3H]OXT-G was incorporated into TK+ VZV-infected cells and TK- VZV-infected cells more than into mock-infected cells and was converted into the triphosphate form.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=245204Documentos Relacionados
- Varicella-zoster virus.
- Inhibitory effects of antiherpesviral thymidine analogs against varicella-zoster virus.
- Monoclonal antibodies against three major glycoproteins of varicella-zoster virus.
- Neutralizing antibody responses to varicella-zoster virus.
- Polymerase chain reaction: detection of varicella-zoster virus.